Bone tissue engineering. Reconstruction of critical sized segmental bone defects in the ovine tibia;Knochen-tissue-engineering Rekonstruktion segmentaler knochendefekte kritischer größe in der schafstibia

Orthopade

Volumn 41, Issue 4, 2012, Pages 280-287

  Reichert, J C ^a,b   Epari, D R ^a   Wullschleger, M E ^a   Berner, A ^a,c   Saifzadeh, S ^a   Noth U ^d   Dickinson, I C ^e   Schuetz, M A ^a   Hutmacher, D W ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Calcium phosphate; Hydroxyapatite; Polycaprolactone; Scaffold; Silk

Indexed keywords

TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE PROSTHESIS; EQUIPMENT; INSTRUMENTATION; PHYSIOLOGY; PROSTHESIS; SHEEP; TIBIA FRACTURE; TISSUE REGENERATION; TREATMENT OUTCOME;

ANIMALS; BONE SUBSTITUTES; EQUIPMENT FAILURE ANALYSIS; GUIDED TISSUE REGENERATION; OSTEOGENESIS; PROSTHESIS DESIGN; SHEEP; TIBIAL FRACTURES; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84863711660     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-011-1855-x     Document Type: Article

References (33)

1. Abbah SA, Lam CX, Hutmacher DW et al (2009) Biological performance of a polycaprolactonebased scaffold used as fusion cage device in a large animal model of spinal reconstructive surgery. Biomaterials 30(28):5086-5093
2. Asahina I, Sampath TK, Nishimura I, Hauschka PV (1993) Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J Cell Biol 123(4):921-933 (Pubitemid 23333580)
3. Auer JA, Goodship A, Arnoczky S et al (2007) Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use. BMC Musculoskelet Disord 8:72
4. Banfi A, Muraglia A, Dozin B et al (2000) Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28(6):707-715 (Pubitemid 30398528)
5. Bhumiratana S, Grayson WL, Castaneda A et al (2011) Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds. Biomaterials 32(11):2812-2820
6. Bloemers FW, Blokhuis TJ, Patka P et al (2003) Autologous bone versus calcium-phosphate ceramics in treatment of experimental bone defects. J Biomed Mater Res B Appl Biomater 66(2):526-531 (Pubitemid 37517124)
7. Blumenthal NM, Koh-Kunst G, Alves ME et al (2002) Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon. J Periodontol 73(12):1494-1506 (Pubitemid 36131621)
8. Bucholz RW, Carlton A, Holmes RE (1987) Hydroxyapatite and tricalcium phosphate bone graft substitutes. Orthop Clin North Am 18(2):323-334 (Pubitemid 17061158)
9. Calori GM, Mazza E, Colombo M et al (2011) Treatment of long bone non-unions with polytherapy: indications and clinical results. Injury 42 (6):587-590
10. Cheng H, Jiang W, Phillips FM et al (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg [Am] 85(8):1544-1552 (Pubitemid 36951140)
11. De Long WG Jr, Einhorn TA, Koval K et al (2007) Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg 89(3):649-658 (Pubitemid 46365369)
12. Boer FC den, Wippermann BW, Blokhuis TJ et al (2003) Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J Orthop Res 21(3):521-528 (Pubitemid 36546819)
13. Doerr HW, Cinatl J, Sturmer M, Rabenau HF (2003) Prions and orthopedic surgery. Infection 31(3):163-171 (Pubitemid 36737038)
14. Friedlaender GE, Perry CR, Cole JD et al (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg [Am]83(1):151-158
15. Harkin DG, George KA, Madden PW et al (2011) Silkfibroin in oculartissue reconstruction. Biomaterials 32(10):2445-2458
16. Hutmacher DW, Schantz JT, Lam CX et al (2007) State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 1 (4):245-260
17. Ilizarov GA (1989) The tension-stress effect on the genesis and growth of tissues: part II. The influence of the rate and frequency of distraction. Clin Orthop Relat Res 239:263-285 (Pubitemid 19060618)
18. Mageed AS, Pietryga DW, DeHeer DH, West RA (2007) Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: characterization of fresh mesenchymal stem cells. Transplantation 83(8):1019-1026 (Pubitemid 46659112)
19. Marolt D, Augst A, Freed LE et al (2006) Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors. Biomaterials 27(36):6138-6149 (Pubitemid 44437575)
20. Meinel L, Karageorgiou V, Hofmann S et al (2004) Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A71(1):25-34 (Pubitemid 39244392)
21. Mikos AG, Herring SW, Ochareon P et al (2006) Engineering complex tissues. Tissue Eng 12(12)3307-3339 (Pubitemid 46037158)
22. Na K, Kim SW, Sun BK et al (2007) Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials 28(16):2631-2637 (Pubitemid 46389528)
23. Nazarov R, Jin HJ, Kaplan DL (2004) Porous 3-D scaffolds from regenerated silkfibroin. Biomacromolecules 5(3):718-726 (Pubitemid 38702237)
24. Onishi T, Ishidou Y, Nagamine T et al (1998) Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone22(6):605-612 (Pubitemid 28284608)
25. Petite H, Viateau V, Bensaid W et al (2000) Tissueengineered bone regeneration. Nat Biotechnol 18(9):959-963
26. Pneumaticos SG, Triantafyllopoulos GK, Basdra EK, Papavassiliou AG (2010) Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments. J Cell Mol Med 14(11):2561-2569
27. Radin SR, Ducheyne P (1994) Effect of bioactive ceramic composition and structure on in vitro behavior. III. Porous versus dense ceramics. J Biomed Mater Res 28(11):1303-1309 (Pubitemid 24313695)
28. Reichert JC, Epari DR, Wullschleger ME et al (2010) Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Eng Part BRev 16(1):93-104
29. Reichert JC, Wullschleger ME, Cipitria A et al (2011) Custom-made composite scaffolds for segmental defect repair in long bones. Int Orthop 35(8):1229-1236
30. Rockwood DN, Gil ES, Park SH et al (2011) Ingrowth of human mesenchymal stem cells into porous silk particle reinforced silk composite scaffolds: an in vitro study. Acta Biomater 7(1):144-151
31. Rubin H (2001) The role of selection in progressive neoplastic transformation. Adv Cancer Res 83:159-207 (Pubitemid 32959265)
32. Shahdadfar A, Fronsdal K, Haug T et al (2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23(9):1357-1366 (Pubitemid 41504923)
33. Terheyden H, Wang H, Warnke PH et al (2003) Acceleration of callus maturation using rhOP-1 in mandibular distraction osteogenesis in a rat model. Int J Oral Maxillofac Surg 32(5):528-533 (Pubitemid 38263354)